Novel medication more effective for patients with relapsed blood cancer
New Delhi: The hematopoietic cell transplant team at Osaka Metropolitan University Graduate School of Medicine has developed a novel technique based on a new drug combination that has shown considerable anti-cancer activity with low toxicity for relapsed/refractory acute myeloid leukemia (AML) patients. Furthermore, the precise immunological study demonstrated how a novel medicine increased anti-cancer activity